Fair Value Measurements (Narrative) (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended				6 Months Ended
	Dec. 31, 2013	Dec. 31, 2013 Rising Pharmaceuticals Inc. [Member]	Jun. 30, 2013 Rising Pharmaceuticals Inc. [Member]	Dec. 31, 2013 France Company [Member]	Dec. 31, 2013 Interest Rate Swap [Member] Cash Flow Hedging [Member]	Dec. 31, 2013 Foreign Currency Contract [Member]	Dec. 31, 2012 Foreign Currency Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount					$ 20,000	$ 66,304
Unrealized gains (losses) on hedging activities						141	381
Derivative, expiration date					Dec. 31, 2015
Unrealized loss on interest rate swap	186
Interest rate swap, remaining balance	10,250
Contingent consideration at fair value		$ 5,604	$ 5,346	$ 399